Diagnosis and Treatment of Hip and Knee Osteoarthritis

医学 骨关节炎 关节痛 度洛西汀 物理疗法 膝关节痛 内科学 病理 替代医学
作者
Jeffrey N. Katz,Kaetlyn R. Arant,Richard F. Loeser
出处
期刊:JAMA [American Medical Association]
卷期号:325 (6): 568-568 被引量:817
标识
DOI:10.1001/jama.2020.22171
摘要

Osteoarthritis (OA) is the most common joint disease, affecting an estimated more than 240 million people worldwide, including an estimated more than 32 million in the US. Osteoarthritis is the most frequent reason for activity limitation in adults. This Review focuses on hip and knee OA.Osteoarthritis can involve almost any joint but typically affects the hands, knees, hips, and feet. It is characterized by pathologic changes in cartilage, bone, synovium, ligament, muscle, and periarticular fat, leading to joint dysfunction, pain, stiffness, functional limitation, and loss of valued activities, such as walking for exercise and dancing. Risk factors include age (33% of individuals older than 75 years have symptomatic and radiographic knee OA), female sex, obesity, genetics, and major joint injury. Persons with OA have more comorbidities and are more sedentary than those without OA. The reduced physical activity leads to a 20% higher age-adjusted mortality. Several physical examination findings are useful diagnostically, including bony enlargement in knee OA and pain elicited with internal hip rotation in hip OA. Radiographic indicators include marginal osteophytes and joint space narrowing. The cornerstones of OA management include exercises, weight loss if appropriate, and education-complemented by topical or oral nonsteroidal anti-inflammatory drugs (NSAIDs) in those without contraindications. Intra-articular steroid injections provide short-term pain relief and duloxetine has demonstrated efficacy. Opiates should be avoided. Clinical trials have shown promising results for compounds that arrest structural progression (eg, cathepsin K inhibitors, Wnt inhibitors, anabolic growth factors) or reduce OA pain (eg, nerve growth factor inhibitors). Persons with advanced symptoms and structural damage are candidates for total joint replacement. Racial and ethnic disparities persist in the use and outcomes of joint replacement.Hip and knee OA are highly prevalent and disabling. Education, exercise and weight loss are cornerstones of management, complemented by NSAIDs (for patients who are candidates), corticosteroid injections, and several adjunctive medications. For persons with advanced symptoms and structural damage, total joint replacement effectively relieves pain.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Carkeke发布了新的文献求助30
刚刚
小于发布了新的文献求助10
刚刚
不安青牛应助弥淮采纳,获得10
1秒前
研友_nq5kKn发布了新的文献求助10
1秒前
mouxq发布了新的文献求助10
1秒前
1秒前
山山而川发布了新的文献求助10
1秒前
洁净归尘发布了新的文献求助10
2秒前
研友_ZGR0jn发布了新的文献求助10
2秒前
刘刘发布了新的文献求助10
2秒前
AaoTii完成签到,获得积分10
3秒前
3秒前
傻傻的孤云完成签到,获得积分10
4秒前
卜学英完成签到,获得积分10
5秒前
小哲子完成签到,获得积分10
5秒前
任性的凡发布了新的文献求助10
5秒前
6秒前
zll发布了新的文献求助10
6秒前
CipherSage应助潇洒雁枫采纳,获得10
6秒前
小二郎应助Nano采纳,获得10
6秒前
LLLBoris发布了新的文献求助10
6秒前
8秒前
研友_ZGR0jn完成签到,获得积分10
8秒前
Dicy发布了新的文献求助10
8秒前
完美世界应助Heart采纳,获得10
10秒前
10秒前
juanjuan发布了新的文献求助10
11秒前
zeannezg完成签到 ,获得积分10
12秒前
SOLOMON应助ref:rain采纳,获得10
13秒前
芷兰丁香完成签到,获得积分10
13秒前
14秒前
hf发布了新的文献求助10
14秒前
WCQ发布了新的文献求助20
14秒前
15秒前
Carkeke完成签到,获得积分10
15秒前
15秒前
15秒前
15秒前
LY发布了新的文献求助10
15秒前
可爱的函函应助LLLBoris采纳,获得10
16秒前
高分求助中
Manual of Clinical Microbiology, 4 Volume Set (ASM Books) 13th Edition 1000
Sport in der Antike 800
De arte gymnastica. The art of gymnastics 600
少脉山油柑叶的化学成分研究 530
Electronic Structure Calculations and Structure-Property Relationships on Aromatic Nitro Compounds 500
Berns Ziesemer - Maos deutscher Topagent: Wie China die Bundesrepublik eroberte 500
Stephen R. Mackinnon - Chen Hansheng: China’s Last Romantic Revolutionary (2023) 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 有机化学 工程类 生物化学 纳米技术 物理 内科学 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 电极 光电子学 量子力学
热门帖子
关注 科研通微信公众号,转发送积分 2415496
求助须知:如何正确求助?哪些是违规求助? 2108600
关于积分的说明 5331594
捐赠科研通 1835737
什么是DOI,文献DOI怎么找? 914571
版权声明 561057
科研通“疑难数据库(出版商)”最低求助积分说明 489047